Showing results (391-400 of 415) with videos related to
Sort By:
Pageof 42
Chemical & Pharmaceutical Bulletin|January 4, 2021
Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 2)Nahoko Uchiyama, Junko Hosoe, Toru Miura, et al.Modern Rheumatology|November 9, 2020
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive studyKazuhisa Nakano, Yoshiya Tanaka, Kazuyoshi Saito, et al.Modern Rheumatology|July 30, 2016
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in JapanEiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, et al.Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|March 9, 2010
[Absolute quantification of carminic acid in cochineal extract by quantitative NMR]Naoki Sugimoto, Atsuko Tada, Takako Suematsu, et al.Modern Rheumatology|February 14, 2023
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohortNaohiro Sugitani, Eiichi Tanaka, Eisuke Inoue, et al.Modern Rheumatology|December 17, 2021
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohortEri Sugano, Eiichi Tanaka, Eisuke Inoue, et al.Modern Rheumatology|February 4, 2021
Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settingsMoeko Ochiai, Eiichi Tanaka, Eri Sato, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 3, 2017
[Evaluation for Standardization of <sup>1</sup>H Quantitative NMR Spectroscopy by Round Robin Test]Toru Miura, Naoki Sugimoto, Ryuichi Watanabe, et al.Allergy and Asthma Proceedings|June 30, 2021
Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scoresTomonori Endo, Daiya Asaka, Tsuguhisa Nakayama, et al.International Archives of Allergy and Immunology|August 28, 2020
Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen AllergensTomonori Endo, Daiya Asaka, Tsuguhisa Nakayama, et al.Pageof 42